Selective cyclooxygenase-2 inhibition reduces endothelial dysfunction and improves inflammatory status in patients with intermittent claudication.

Source:http://linkedlifedata.com/resource/pubmed/id/19706240

Download in:

View as

General Info

PMID
19706240